Table 3.

Cancer, Treatment, and Symptom Variables at Baseline by Group

		Group Mean (SD) or n (%)		Statistics
Characteristics	Overall ( n = 65)	WRITE Symptoms n=33	Control n=32	Mann-Whitney/ Chi-square	P-value
Months since diagnosis	51.40 (43.53)	47.53 (31.94)	55.40 (53.16)	−0.07	0.95
No. of prior surgeries	1.72 (0.93)	1.64 (0.78)	1.81 (1.06)	−0.38	0.70
No. of new chemo regimens	3.67 (2.19)	3.31 (1.66)	4.03 (2.60)	−0.99	0.32
Stage at diagnosis	n (%)	n (%)	n (%)	4.73	0.30
Stage I	4 ( 6.2%)	3 (9.1%)	1 (3.1%)		(Fisher’s)
Stage II	8 (12.3%)	2 (6.1%)	6 (18.8%)
Stage III	44 (67.7%)	23 (69.7%)	21 (65.6%)
Stage IV	7 (10.8%)	3 (9.1%)	4 12.5%)
Don’t know	2 ( 3.1%)	2 (6.1%)	0
Prior Radiotherapy:				2.16	0.19
Yes	5 (7.8%)	1 (3.0%)	4 (12.9%)		(Fisher’s)
No	59(92.2%)	32 (97.0%)	27 (87.1%)
Current Ca-125 Level:	150.62 (323.77)	124.18 (273.02)	177.93 (371.83)	−0.14	0.89
Current evidence of disease?
Yes	54 (83.1%)	29 (87.9%)	25 (78.1%)	1.10	0.29
Currently receiving chemo?
Yes	52 (80.0%)	28 (84.8%)	24 (75.0%)	0.985	0.32
Symptom Representations
Symptom Severity		6.05 (2.45)	5.69 (2.60)	t(63)=0.58	0.56
Symptom Consequences		2.02 (0.59)	1.90 (0.73)	t(63)=0.71	0.48
Symptom Controllability		2.07 (0.62)	2.12 (0.66)	t(63)=−0.30	0.76
Symptom Distress		1.91 (0.79)	1.81 (0.96)	t(63)=0.46	0.65